1-4 of 4
Vincent Chung
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C048: Novel master checkpoint Cbl-b siRNA-based adoptive cellular therapy: Superior antitumor efficacy in a syngeneic murine hepatocellular carcinoma Hepa1-6 model following APN401 monotherapy and synergistic effects with anti-PD1

Free
Anderson Gaweco, Kathrin Thell, Maria Urban, Julia Harrauer, Isabella Haslinger, Alexander Dohnal, Guenther Lametschwandtner, Karin Drobits, Romana Gugenberger, Hannes Muehleisen, Josef Penninger, Carlos Becerra, Vincent Chung, Anthony El-Khoueiry
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C048.
https://doi.org/10.1158/1535-7163.TARG-19-C048
Published: 01 December 2019
View articletitled, Abstract C048: Novel master checkpoint Cbl-b siRNA-based adoptive cellular therapy: Superior antitumor efficacy in a syngeneic murine hepatocellular carcinoma Hepa1-6 model following APN401 monotherapy and synergistic effects with anti-PD1
Journal Articles

Abstract C053: NP-G2-044, a novel fascin inhibitor, blocks tumor metastasis and increases antitumor immune response

Free
Vincent Chung, Frank Tsai, Komal Jhaveri, Yufeng Wang, Daniel D Von Hoff, Edward G Garmey, J. Jillian Zhang, Xin-Yun Huang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C053.
https://doi.org/10.1158/1535-7163.TARG-19-C053
Published: 01 December 2019
View articletitled, Abstract C053: NP-G2-044, a novel fascin inhibitor, blocks tumor metastasis and increases antitumor immune response
Journal Articles

Abstract A175: A phase 1 study of a novel inhibitor of protein phosphatase 2A alone or in combination with docetaxel

Free
Vincent Chung, Donald Richards, Fadi Braiteh, John S. Kovach, Aaron Scott Mansfield
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): A175.
https://doi.org/10.1158/1535-7163.TARG-15-A175
Published: 01 December 2015
View articletitled, Abstract A175: A phase 1 study of a novel inhibitor of protein phosphatase 2A alone or in combination with docetaxel
Journal Articles

SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone

Free
Vincent Chung, Bingsen Zhou, Xiyong Liu, Lijun Zhu, Lee M. Boo, Ha-Van Nguyen, David K. Ann, Jing Song, Yuan Chen, Yun Yen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (3): 533–540.
https://doi.org/10.1158/1535-7163.MCT-05-0290
Published: 16 March 2006
View articletitled, SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone
Open the PDF for SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone in another window